10-Q: Waystar Reports Strong Q2 2026 Financial Results
Quarterly Report
Waystar Holding Corp. announced robust financial performance for the second quarter of 2026, with significant year-over-year growth in revenue and net income.
Summary
- Waystar Holding Corp. reported revenue of $319.7 million for the three months ended June 30, 2026, an 18.1% increase compared to the same period in 2025.
- Net income for the quarter was $40.9 million, a 27.0% increase from $32.2 million in the prior year's second quarter.
- For the six months ended June 30, 2026, revenue grew 20.2% to $633.5 million, and net income increased 36.9% to $84.2 million.
- Adjusted EBITDA for the six-month period was $272.1 million, up 23.5% from $220.3 million in the prior year.
- The company's Net Revenue Retention Rate was 108.3% for the twelve months ended June 30, 2026, indicating strong client retention and growth.
- The number of clients generating over $100,000 in revenue increased to 1,453 as of June 30, 2026.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this filing positively due to strong revenue and net income growth, high client retention, and efficient operations, indicating a healthy and expanding business.
Positives
- Revenue increased by 18.1% to $319.7 million for the three months ended June 30, 2026, compared to the prior year.
- Net income rose by 27.0% to $40.9 million for the three months ended June 30, 2026.
- Six-month revenue increased by 20.2% to $633.5 million.
- Six-month net income increased by 36.9% to $84.2 million.
- Adjusted EBITDA for the six months ended June 30, 2026, increased by 23.5% to $272.1 million.
- Net Revenue Retention Rate of 108.3% for the twelve months ended June 30, 2026, shows strong client expansion.
- The number of clients generating over $100,000 in revenue grew to 1,453.
Negatives
- Cost of revenue increased by 12.2% to $97.7 million for the three months ended June 30, 2026.
- General and administrative expenses increased by 24.6% to $36.4 million for the three months ended June 30, 2026.
- Research and development expenses increased by 40.4% to $17.7 million for the three months ended June 30, 2026.
- Depreciation and amortization expense increased by 24.1% to $41.5 million for the three months ended June 30, 2026.
- Net cash provided by operating activities decreased by 10.4% to $144.3 million for the six months ended June 30, 2026.
- Net cash used in investing activities increased significantly by 195.0% to $182.1 million for the six months ended June 30, 2026.
Risks
- The company is subject to risks common to companies in similar industries, including intense competition, client retention, business strategy execution, and acquisition integration.
- Reliance on senior management and key employees, and the ability to attract and retain skilled personnel.
- Potential for errors or malfunctions in products and solutions.
- Privacy concerns, security breaches, and evolving data protection and cybersecurity laws.
- The complex and evolving healthcare regulatory and political framework.
- Substantial debt and restrictive covenants in credit facility agreements.
- The company has a history of net losses and its ability to achieve or maintain profitability.
- The potential impact of macroeconomic conditions on business operations.
Future Outlook
The company's business model aligns with client growth, and it expects continued growth in revenue driven by increased patient volumes and adoption of more solutions. The company believes its existing cash, expected future cash flows, and potential additional borrowings will be sufficient to fund operations, capital expenditures, and debt service for at least the next 12 months and beyond.
Management Comments
- "Our enterprise-grade platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in better transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow."
- "We leverage AI as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, strengthens data integrity, and reduces labor costs for providers."
- "Our platform benefits from powerful network effects. Our cloud-based software is driven by a sophisticated, automated, and AI-powered engine to generate and incorporate real-time feedback from millions of network transactions processed through our platform each day."
- "As we capture more data from each transaction we process, we leverage those insights to continuously improve the platform through Waystar AltitudeAI, our proprietary AI engine."
- "We have demonstrated an ability to drive recurring, predictable, and profitable growth. Over 99% of our revenue is either recurring subscription or based on highly predictable volumes."
Industry Context
StockSavvy.ai notes that Waystar's strong performance in the healthcare technology sector, particularly its focus on AI-powered solutions for payment processing, aligns with broader industry trends towards automation and efficiency in healthcare administration. The company's ability to maintain a high Net Revenue Retention Rate suggests effective client engagement and value delivery in a competitive landscape.
Comparison to Industry Standards
- Waystar's Net Revenue Retention Rate of 108.3% for the twelve months ended June 30, 2026, is generally considered strong within the SaaS industry, where rates often range from 90% to 110%.
- The company's revenue growth of 20.2% for the first six months of 2026 is robust, especially for a company of its size, and compares favorably to the average growth rates seen in the broader healthcare IT sector.
- Adjusted EBITDA margin of 43.0% for the six months ended June 30, 2026, indicates strong operational efficiency, which is a key benchmark for profitability in the technology services industry.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Steven M. Oreskovich | Alpana Wegner | 2026-08-01 | Transition to new CFO with extensive financial leadership experience. |
| Strategic Advisor | Steven M. Oreskovich | Steven M. Oreskovich | 2026-07-28 | Transition to advisory role after departing as CFO. |
Legal Proceedings
- The company may be subject to legal proceedings, claims, and litigation arising in the ordinary course of business, but does not currently expect these to have a material adverse effect on its financial position, results of operations, or cash flows.
Related Party Transactions
- Outstanding debt of $77.0 million as of June 30, 2026, from Bain Affiliated Funds and CPPIB Credit Investments III Inc.
- Interest expense of $1.0 million for the three months ended June 30, 2026, paid to affiliated debtholders.
- Revenue of $0.8 million earned from clients in which Bain has a significant interest for the three months ended June 30, 2026.
- Expenses of $0.6 million for software services from vendors in which Bain has a significant interest for the three months ended June 30, 2026.
- Revenue of $0.5 million earned from customers in which Advent has a significant interest for the three months ended June 30, 2026.
Stakeholder Impact
- Shareholders: Continued revenue and net income growth, strong retention rates, and a stock repurchase plan may positively impact shareholder value.
- Employees: Increased R&D and G&A expenses, including stock-based compensation, suggest investment in personnel and operations.
- Clients: Continued platform improvements driven by AI and data insights are expected to enhance service delivery and financial outcomes.
- Creditors: The company's substantial debt and restrictive covenants require careful monitoring of financial performance and liquidity.
Next Steps
- Continue to expand relationships with existing clients through cross-selling and up-selling.
- Focus on growing the client base by maintaining product leadership and investing in R&D.
- Integrate acquired businesses, such as Iodine, to bolster AI leadership and financial performance.
- Monitor and manage cybersecurity risks and data privacy compliance.
- Continue to leverage AI through Waystar AltitudeAI to improve platform performance and client value.
Key Dates
| Date | Description |
|---|---|
| 2025-02-17 | Filing of the 2025 Form 10-K. |
| 2025-02-24 | Closing of the First Secondary Offering. |
| 2025-05-15 | Closing of the Second Secondary Offering. |
| 2025-09-10 | Closing of the Third Secondary Offering. |
| 2025-10-01 | Completion of the Iodine acquisition. |
| 2026-02-13 | Amendment to the Receivables Facility increasing credit availability and extending maturity. |
| 2026-02-23 | Repayment on the First Lien Credit Facility using funds from the Receivables Facility amendment. |
| 2026-07-27 | Compensation Committee approved amendment to outstanding option awards. |
Recommendation
holdWaystar demonstrates strong operational performance with solid revenue growth and profitability. However, the increase in operating expenses, particularly in R&D and G&A, coupled with significant debt levels and ongoing investments, warrants a 'hold' recommendation pending further clarity on long-term profitability and debt management.
Keywords
Healthcare Technology, Revenue Growth, Net Income, Adjusted EBITDA, Net Revenue Retention, Cloud Technology, AI, Financial Performance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.